X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with SUVEN LIFE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs SUVEN LIFE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE SUVEN LIFE TTK HEALTHCARE/
SUVEN LIFE
 
P/E (TTM) x 51.5 19.8 260.1% View Chart
P/BV x 9.5 3.7 258.3% View Chart
Dividend Yield % 0.3 1.0 30.0%  

Financials

 TTK HEALTHCARE   SUVEN LIFE
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
SUVEN LIFE
Mar-16
TTK HEALTHCARE/
SUVEN LIFE
5-Yr Chart
Click to enlarge
High Rs663339 196.0%   
Low Rs399144 276.3%   
Sales per share (Unadj.) Rs535.639.2 1,364.8%  
Earnings per share (Unadj.) Rs15.97.5 213.7%  
Cash flow per share (Unadj.) Rs20.08.8 228.2%  
Dividends per share (Unadj.) Rs4.002.00 200.0%  
Dividend yield (eoy) %0.80.8 90.9%  
Book value per share (Unadj.) Rs137.649.0 280.9%  
Shares outstanding (eoy) m7.77127.28 6.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.06.2 16.1%   
Avg P/E ratio x33.332.4 102.9%  
P/CF ratio (eoy) x26.527.5 96.4%  
Price / Book Value ratio x3.94.9 78.3%  
Dividend payout %25.126.8 93.6%   
Avg Mkt Cap Rs m4,12730,732 13.4%   
No. of employees `0001.71.0 179.0%   
Total wages/salary Rs m607416 145.7%   
Avg. sales/employee Rs Th2,436.75,236.1 46.5%   
Avg. wages/employee Rs Th355.2436.5 81.4%   
Avg. net profit/employee Rs Th72.5995.5 7.3%   
INCOME DATA
Net Sales Rs m4,1624,995 83.3%  
Other income Rs m61194 31.6%   
Total revenues Rs m4,2235,189 81.4%   
Gross profit Rs m1971,233 16.0%  
Depreciation Rs m32167 19.0%   
Interest Rs m3054 55.2%   
Profit before tax Rs m1971,205 16.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m73255 28.5%   
Profit after tax Rs m124950 13.0%  
Gross profit margin %4.724.7 19.2%  
Effective tax rate %37.021.2 174.9%   
Net profit margin %3.019.0 15.7%  
BALANCE SHEET DATA
Current assets Rs m1,6294,986 32.7%   
Current liabilities Rs m1,0581,042 101.5%   
Net working cap to sales %13.779.0 17.4%  
Current ratio x1.54.8 32.2%  
Inventory Days Days3061 48.8%  
Debtors Days Days3439 85.8%  
Net fixed assets Rs m5563,126 17.8%   
Share capital Rs m78127 61.0%   
"Free" reserves Rs m8783,717 23.6%   
Net worth Rs m1,0696,236 17.1%   
Long term debt Rs m159432 36.7%   
Total assets Rs m2,3998,079 29.7%  
Interest coverage x7.623.2 32.6%   
Debt to equity ratio x0.10.1 214.1%  
Sales to assets ratio x1.70.6 280.5%   
Return on assets %6.412.4 51.6%  
Return on equity %11.615.2 76.1%  
Return on capital %18.518.9 97.7%  
Exports to sales %0.887.5 0.9%   
Imports to sales %1.412.2 11.5%   
Exports (fob) Rs m334,371 0.8%   
Imports (cif) Rs m58611 9.5%   
Fx inflow Rs m334,666 0.7%   
Fx outflow Rs m63942 6.7%   
Net fx Rs m-303,724 -0.8%   
CASH FLOW
From Operations Rs m127922 13.7%  
From Investments Rs m-146-619 23.6%  
From Financial Activity Rs m22-698 -3.1%  
Net Cashflow Rs m3-396 -0.6%  

Share Holding

Indian Promoters % 65.4 63.4 103.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 0.0 -  
FIIs % 5.2 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 36.5 70.7%  
Shareholders   12,723 37,287 34.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   AJANTA PHARMA  GLENMARK PHARMA  SHASUN PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Rebound After Sharp Weekly Drop(RoundUp)

Global financial markets rallied this week and brushed aside a rise in global borrowing costs while the dollar hit its lowest level since 2014.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

As the Market Corrects... It's Time to Buy More(Smart Contrarian)

Feb 5, 2018

The recent sell off in the stock market offers buying opportunity in some quality small caps.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Feb 16, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS